4-Bromo-1H-pyrrolo[2,3-c]pyridine-3-carboxylic acid, 97%, 500mg

9-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-9H-carbazole, 95.0%, 100g

(5-Bromo-2-chloro-phenyl)-hydrazine, 95.0%, 100mg

4-Amino-N-((2R,3S)-3-amino-2-hydroxy-4-phenylbutyl)-N-isobutylbenzenesulfonamide, 95.0%, 1g

6-Bromo-5-chloropyridin-2-amine, 95.0%, 10g

ALISKIREN HEMIFUMARATE, 95%, 50mg

(R)-3,3'-DIBROMO-2,2'-BIS(METHOXYMETHOXY)-1,1'-BINAPHTHYL, 95%, 1g

ETHYL 3-(2-((4-CARBAMOYLPHENYLAMINO)METHYL)-1-METHYL-N-(PYRIDIN-2-YL)-1H-BENZO[D]IMIDAZOLE-5-CARBOXAMIDO)PROPANOATE, 95%, 50mg

2-(4-Amino-2-fluorophenyl)acetic acid, 95.0%, 250mg

Methyl DL-Mandelate>98.0%(GC)25g

Tantal ICP-Standardlösung, ROTI®Star, 1000 mg/l Ta, Dichte (D) ~1 g/cm³

2-chloro-4H-1,3-benzothiazin-4-one, 95.0%, 250mg

5-HEPTENOIC ACID, 7-[(1R,2R,3R,5S)-3,5-DIHYDROXY-2-[(1E,3R)-3-HYDROXY-4-[3-(TRIFLUOROMETHYL)PHENOXY]-1-BUTEN-1-YL]CYCLOPENTYL]-, 1-METHYLETHYL ESTER, (5Z)-, 98%, 50mg